Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study (NCT05455086) | Clinical Trial Compass
CompletedNot Applicable
Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study
United States21 participantsStarted 2022-03-23
Plain-language summary
This clinical trial studies the effect of free-base compared with nicotine salt based e-liquids on electronic cigarette (EC) puffing behavior, abuse liability, and deposition and absorption of nicotine in the respiratory tract and rate of uptake in the brain in current EC smokers. The results from this study may provide much needed scientific information to public health officials and regulators.
Who can participate
Age range21 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* A current exclusive e-cigarette user (\>= 1 vaping bout per day) for at least the past 6 months (confirmed by NicAlert saliva testing strip)
* Between 21-50 years old
* Willing to provide informed consent and abstain from all tobacco and nicotine use for at least 12 hours prior to visits 2 and 3
* Willing to participate in 3 laboratory visits
* Read and speak English
* If utilizing study provided rideshare services, will need to live within 20 miles of Wake Forest University
Exclusion Criteria:
* Self-reported diagnosis of lung disease including asthma, cystic fibrosis, or chronic obstructive pulmonary disease
* Unstable or significant psychiatric conditions (past and stable conditions will be allowed)
* History of cardiac event or distress within the past 3 months
* Currently pregnant (as indicated by urine pregnancy test at the start of each laboratory visit), planning to become pregnant, or breastfeeding (women only)
* Use of other tobacco products (e.g., cigarette, cigar, etc.) \> 5 days in the past month
* Currently engaging in a tobacco product cessation attempt